Wegovy-maker Novo Nordisk's CEO Mike Doustdar will face pressure on ​Monday to set out his strategy

I screen U.S.-listed dividend growth stocks with 2–6% yields, strong revenue growth, and disciplined

A member of Congress recently disclosed numerous stock trades, with some new names bought and some o

A US congressman sold some Magnificent Seven stocks and replaced them with a couple consumer staples

PrSandoz® Semaglutide, a generic version of PrOzempic®, approved for the treatment of adult patients

NVO's denecimig wins a positive European opinion for hemophilia A, with flexible dosing and a potent

Raul Shah (@Raul_DSF) is very bullish on the future of GLP-1s due to accelerating demand trends gene

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has

Novo Nordisk A/S (NYSE:NVO) stock is trading higher on Thursday after the Danish drug maker achieved

Novo Nordisk wins CHMP recommendation for hemophilia drug FREHEMGO and enters a $1.4 billion cardiom

LLY's GLP-1 momentum, Foundayo launch and retatrutide pipeline support growth, but premium valuation

NVO is expanding its AI strategy with Anthropic to tackle drug discovery challenges, boost R&D produ

NVO's 5% drop in a week reflects intensifying GLP-1 competition and semaglutide risks, but its broad

https://www.globenewswire.com/news-release/2026/09/17/3364155/0/en/novo-chmp-recommends-eu-approval-

Orbis Medicines said on Thursday it had signed a drug discovery and licensing deal with Novo Nordisk

COPENHAGEN, Denmark--(BUSINESS WIRE)--Orbis Medicines, a leader in oral macrocycle drug discovery, t

Novo Nordisk (NVO) closed the most recent trading day at $41.67, moving 2.02% from the previous trad

Novo Nordisk and Anthropic strike a partnership to leverage Claude and other AI models in the drug d

Novo Nordisk has lost its lead in the weight loss market. The company could face even more competiti

Artelo Biosciences shares new nonclinical data showing its oral cannabinoid drug ART27.13 matches se

Novo Nordisk taps Anthropic AI to speed medicine research, enhance software workflows, and implement

PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper dr

Ascendis Pharma shares dip as it reclaims TransCon technology rights from Novo Nordisk and initiates

A landmark trial just proved semaglutide can pull children as young as six below the obesity thresho

Novo Nordisk (NVO) shares fell 2% on Tuesday even after the drugmaker introduced a new brand identit

Novo Nordisk's CEO Mike Doustdar on Tuesday urged employees to be more customer-focused, ​as the Weg

Novo Nordisk is bigger and more profitable on paper, but pricing pressure, reduced Medicaid coverage

Novo faces a tougher growth outlook as Morgan Stanley downgrades the stock to Underweight, citing mu

Zacks.com users have recently been watching Novo Nordisk (NVO) quite a bit. Thus, it is worth knowin

Novo Nordisk is changing its day-to-day name to 'Novo', and taking a new approach ​to company cultur

The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs

Novo Nordisk rebrands as 'Novo' as it seeks to regain obesity drug market share and unveils

The drugmaker said its new name aims to make it more recognizable to compete in the market for obesi

Analysts downgraded Novo Nordisk, Chewy, NuScale Power and Atmos Energy, cutting price targets for t

Morgan Stanley analyst Thibault Boutherin downgrades Novo Nordisk (NYSE:NVO) from Equal-Weight to

Novo Nordisk Phase 3 STEP Young trial shows once-weekly semaglutide reduced BMI in 40.4% of children

FDA warns of risks from unapproved compounded GLP-1 drugs including semaglutide and tirzepatide amid

Trump secures drug pricing deals with nine pharma companies as Kennedy reveals intense pressure from

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Boston Scientific reports a cyber incident disrupting global operations, limiting system access and

For adults over the age of 55, including patients in Medicare's GLP-1 Bridge program, these lowe

This whale alert can help traders discover the next big trading opportunities. Whales are entities w